- Investing Ideas
- Taiwanese Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Taiwanese Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Results
8
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
8 companies
Caliway Biopharmaceuticals
Market Cap: NT$176.3b
Engages in the development of drugs for aesthetic medicine and chronic inflammation.
6919
NT$111.00
7D
15.9%
1Y
86.9%
Maxigen Biotech
Market Cap: NT$3.8b
Researches, develops, produces, and sells implantable medical devices and cosmetic products in Taiwan, America, Europe, rest of Asia, and internationally.
1783
NT$42.60
7D
-0.2%
1Y
8.1%
SYN-TECH Chem. & Pharm
Market Cap: NT$3.2b
Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.
1777
NT$71.30
7D
-1.2%
1Y
-18.5%
Syngen BiotechLtd
Market Cap: NT$2.9b
Engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan, China, and internationally.
8279
NT$106.50
7D
-1.4%
1Y
-10.5%
HeXun Biosciences
Market Cap: NT$2.8b
Engages in the research and development of stem cell drug development and cardiovascular disease treatments in Taiwan.
6986
NT$59.90
7D
4.5%
1Y
-23.7%
Winston Medical Supply
Market Cap: NT$1.3b
Winston Medical Supply Co.,Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally.
6817
NT$67.50
7D
-6.0%
1Y
-28.3%
Anxo Pharmaceutical
Market Cap: NT$1.1b
A specialty pharmaceutical company, develops, manufactures, and sells pharmaceutical products for medical professionals and patients in Taiwan and internationally.
6677
NT$19.00
7D
-0.5%
1Y
4.4%
Prince Pharmaceutical
Market Cap: NT$1.0b
Manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally.
6935
NT$30.30
7D
9.0%
1Y
43.3%